NuCana (NCNA) Interest Coverage Ratio (2025)
NuCana's (NCNA) quarterly Interest Coverage Ratio came in at 0.11 in Q4 2025, down 111.84% quarter-over-quarter from 0.94 in Q2 2025.
NuCana (NCNA) Interest Coverage Ratio (2025) Analysis & Trends
NuCana has disclosed Interest Coverage Ratio across 1 years of filings, most recently posting 0.11 for Q4 2025.
- Interest Coverage Ratio for Q4 2025 came in at 0.11, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 1.44 (changed N/A YoY), and the FY2025 annual result was 1.59, changed N/A from the prior year.
- Interest Coverage Ratio came in at 0.11 for Q4 2025 at NuCana, down from 0.94 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.94 in Q2 2025 to a low of 0.11 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.11 |
| Jun 30, 2025 | 0.94 |